Identification of the ZAK-MKK4-JNK-TGF&bgr; Signaling Pathway as a Molecular Target for Novel Synthetic Iminoquinone Anticancer Compound BA-TPQ

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 651-660

Bentham Science Publishers

Access to resources Recommend Favorite

Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer

By Dandawate Prasad   Vyas Alok   Ahmad Aamir   Banerjee Sanjeev   Deshpande Jyoti   Swamy K.   Jamadar Abeda   Dumhe-Klaire Anne   Padhye Subhash   Sarkar Fazlul  

Pharmaceutical Research, Vol. 29, Iss. 7, 2012-07 ,pp. : 1775-1786

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro and In Vivo Anticancer Activity of a Novel Nano-sized Formulation Based on Self-assembling Polymers Against Pancreatic Cancer

By Hoskins Clare   Ouaissi Mehdi   Lima Sofia   Cheng Woei   Loureirio Inês   Mas Eric   Lombardo Dominique   Cordeiro-da-Silva Anabela   Ouaissi Ali   Kong Thoo Lin Paul  

Pharmaceutical Research, Vol. 27, Iss. 12, 2010-12 ,pp. : 2694-2703

Springer Publishing Company

Access to resources Recommend Favorite

Novel Colchicine Derivatives and their Anti-cancer Activity

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2538-2558

Bentham Science Publishers

Access to resources Recommend Favorite

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

By  

Current Cancer Drug Targets, Vol. 16, Iss. 5, 2016-06 ,pp. : 455-465

Bentham Science Publishers

Access to resources Recommend Favorite